EGFR and ovarian cancer: In addition, there is reported evidence that YAP1 signaling, which was activated by FAT1 mutation [5], can activate EGFR family members though upregulation of their ligands in ovarian cancer [54], which suggests a potential linkage between YAP1 and EGFR signaling.